Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc (NASDAQ & LSE: FRMI) is having the kind of week that turns a normal stock chart into modern art: sharp gaps, headline-driven swings, and investors trying to separate what’s confirmed from what’s merely energetic speculation. On December 18, 2025, FRMI closed at $8.34, down 7.98% on the day, after opening near $9.31 and trading as high as $9.33 and as low as $8.27—with roughly 7.52 million shares changing hands. Investing.com That move sits on top of an even bigger story: Fermi’s “first tenant” financing arrangement for its flagship Project Matador in Texas was terminated last week, triggering a
18 December 2025
··
Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences Ltd. (NASDAQ: WVE) is back in the spotlight on December 18, 2025—not because of a brand-new press release, but because the stock is still digesting one of the most volatile biotech weeks of the year. In Thursday trading, WVE stock fell roughly mid-single digits, hovering in the mid-$15 range after closing around $16.34 the prior session, according to market data and widely circulated market recaps. StockAnalysis+1 That pullback matters because it comes right after a dramatic early-December surge tied to Wave’s obesity program—and immediately following a large equity financing that materially changes the company’s cash position and
18 December 2025
Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stock slid sharply on Thursday, December 18, 2025, after a regulatory filing revealed a leadership transition involving the company’s Chief Medical and Development Officer. In trading, CRNX fell roughly 8% to around the mid‑$40s, with the day’s range stretching from the low‑$40s to the high‑$40s as investors digested the update. Investing.com For a biotech stock—especially one in the middle of a major product launch and multiple late‑stage trials—management continuity matters. But so do fundamentals: Crinetics is no longer “just” a clinical-stage story. It recently reached a pivotal milestone with its first FDA-approved product, and its
18 December 2025
·
Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Dec. 18, 2025 — Birkenstock Holding plc (NYSE: BIRK) delivered a classic “beat-and-drop” session: strong fiscal 2025 results and record revenue were overshadowed by a more cautious fiscal 2026 outlook that bakes in tariff and currency pressure. SEC+1 As of the latest available trade on Dec. 18, Birkenstock shares were at $42.58, down about 8% on the day, after swinging between $39.73 and $46.75 in heavy volume. The market’s message was blunt: investors liked what Birkenstock just did, but they’re repricing what it may earn next—especially if tariffs and foreign-exchange (FX) headwinds prove sticky. What’s happening with Birkenstock stock today
18 December 2025
··
Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

December 18, 2025 — Edgewise Therapeutics, Inc. (NASDAQ: EWTX) saw its shares slide sharply in Thursday trading, a reminder that clinical-stage biotech stocks can move fast even when there’s no single headline screaming for attention. EWTX finished the session around $20.35, down roughly 8.8% from the prior close, after trading between about $20.33 and $22.81. StockAnalysis That drop matters because the Edgewise story is still mostly about future clinical readouts and regulatory path clarity, not current product revenue. The company is advancing late-stage work in muscular dystrophies (with its lead program, sevasemten) and also developing cardiac sarcomere modulators for conditions
18 December 2025
··
ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries Incorporated (NYSE: ABM) stock was sharply lower in Thursday trading (December 18, 2025), with shares recently changing hands near $43.13, down about 10.6% from the prior close after a volatile session that saw the stock trade between $43.02 and $47.63. The move follows a dense burst of company updates released on December 17: ABM’s fiscal fourth-quarter and full-year 2025 results, a fiscal 2026 outlook, a dividend increase, and a major acquisition announcement—plus fresh analyst commentary today that put margins and leverage back at the center of the debate. GlobeNewswire+2ABM+2 Why ABM stock is moving today The immediate catalyst
18 December 2025
···
Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems, Inc. (NYSE: INSP) stock tumbled sharply on Thursday, December 18, 2025, after a key Medicare coding tailwind that had fueled recent optimism suddenly looked far less certain. By early afternoon in the U.S. session, INSP was down in the mid-to-high teens, reflecting investor anxiety that a reimbursement “upgrade” tied to a specific billing code may not stick—at least not in the clean, nationwide way many had modeled. MarketBeat What happened to INSP stock on 18.12.2025? The immediate catalyst: two Medicare Administrative Contractors (MACs)—CGS and Noridian—reportedly pulled CPT code 64568 for hypoglossal nerve stimulation (HGNS) and redirected billing
18 December 2025
Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

December 18, 2025 — Insmed Incorporated (NASDAQ: INSM) shares dropped sharply Thursday after the company disclosed a Phase 2b setback for brensocatib in a chronic sinus condition and said it is discontinuing development in that indication, even as it simultaneously added a new Phase 2–ready antibody to its pipeline. SEC+1 Insmed stock was trading around $166.75 in the afternoon snapshot available from market data, down about 16% on the day, after touching an intraday low of $158.06 and high of $173.99. What happened to INSM stock on December 18, 2025 The selloff traces back to Insmed’s disclosure that its Phase
18 December 2025
···
Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Holdings, Inc. (NASDAQ: UPST) is back in the spotlight on December 18, 2025 (18.12.2025), with the AI-lending stock pushing higher as traders react to fresh partner momentum in credit unions—and try to square that optimism with a still-volatile macro and a sharply divided analyst community. Shares were trading around the high-$40s on Thursday, up roughly 8% on the session at the time of this writing. Investing.com That move follows a choppy stretch for UPST, where single-day swings have become a feature, not a bug. Today’s catalyst is fairly clear: a new credit union partnership that reinforces Upstart’s strategy of
18 December 2025
·
ICE Barcelona 2026: Malta’s iGaming Push, Property Appeal and the EU’s Ukraine Funding Crunch

ICE Barcelona 2026: Malta’s iGaming Push, Property Appeal and the EU’s Ukraine Funding Crunch

Valletta / Brussels / Barcelona — December 18, 2025.Across Europe today, three storylines converged around the same theme: predictability—who can offer it, who needs it, and how much it costs. In Brussels, EU leaders entered what diplomats described as a make-or-break summit over a proposed €90 billion “reparations loan” for Ukraine, backed by profits from frozen Russian central bank assets—a plan that has exposed deep legal and financial anxieties inside the bloc. Reuters+2The Guardian+2 In the Mediterranean, Malta is leaning hard into the opposite narrative: a small jurisdiction selling stability at scale. On the same day, GamingMalta detailed how it
18 December 2025
BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies, Inc. stock (NYSE: BETA) became one of the more talked-about “future of flight” trades on December 18, 2025, as a classic one-two catalyst landed on the tape: a fresh analyst price-target increase from Bank of America and a major federal policy signal for the advanced air mobility (AAM) sector. By the latest reported trade late Thursday, BETA shares were at $29.88, up 6.83%, after touching an intraday high of $30.49. That price action is happening in a stock that only recently entered the public markets—BETA raised about $1.01 billion in its IPO at $34 per share, debuting on
18 December 2025
·
Karman Holdings (KRMN) Stock: News, Forecasts, and Analyst Outlook for December 18, 2025

Karman Holdings (KRMN) Stock: News, Forecasts, and Analyst Outlook for December 18, 2025

Karman Holdings Inc. (best known as Karman Space & Defense) is back on investors’ radar on Thursday, December 18, 2025, as fresh institutional ownership data and new valuation commentary collide with an already-heated 2025 run in aerospace and defense equities. One important housekeeping note up front: Karman Holdings Inc. trades on the NYSE under ticker KRMN—not ONDS. Reuters+1ONDS is the ticker for Ondas Holdings Inc., a separate defense-and-autonomy company that also made news today. Ondas Holdings Inc. With that clarified, here’s what’s new (and what matters) for Karman (KRMN) stock as of 12/18/2025, pulling together the day’s news, forecasts, and
18 December 2025
·
1 … 621 622 623 624 625 … 890

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop